NCT04079517View on ClinicalTrials.gov

Karolinska Interventional Study of Mammograhic Density (Karisma-1)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Breast CancerMammographic Density
Interventions
DRUG

Tamoxifen

A registered SERM drug, Tamoxifen.

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT04079517 - Karolinska Interventional Study of Mammograhic Density (Karisma-1) | Biotech Hunter | Biotech Hunter